Hyperion DeFi Inc. (HYPD)
HYPD trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$3.36
-3.17% on the day
Market cap
$51.9M
Micro cap
Revenue · 2025
$813K
+1318.8% on 2024
Net income · 2025
-$45.3M
-5570.6% net margin
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC XBRL frames, calendar 2025.
Profile
| Field | Value |
|---|---|
| Ticker | HYPD on Nasdaq |
| Sector | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Country | United States |
| IPO year | 2018 |
| SEC CIK | 0001682639 |
| SEC industry code | Finance Services |
| Incorporated in | DE |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $813K |
| Net income | -$45.3M |
| Operating income | -$46.7M |
| Net margin | -5570.6% |
| Operating margin | -5743.5% |
| Revenue growth | +1318.8% |
| Cash | $6.3M |
| Total assets | $51.8M |
| P/E (computed) | Net income was not positive |
| P/S (computed) | 63.8× |
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | 424B5 | 2026-05-06 |
| Latest annual report | 10-K | 2026-03-30 |
| Latest quarterly / interim | 10-Q | 2026-08-13 |
| Latest current report FORM 8-K | 8-K | 2026-10-02 |
| Latest proxy | DEFA14A | 2026-05-05 |
Source: SEC EDGAR submissions feed, 612 recent filings. All filings on EDGAR.
Peers in Biotechnology: Pharmaceutical Preparations
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| ATHE | Alterity Therapeutics Limited | $2.85 | -2.73% | $51.9M |
| RNXT | RenovoRx Inc. | $1.15 | -8.00% | $51.9M |
| MREO | Mereo BioPharma Group plc | $0.3200 | +1.52% | $51.1M |
| IBIO | iBio Inc. | $0.7818 | -13.44% | $50.3M |
| ALDX | Aldeyra Therapeutics Inc. | $0.8998 | -0.66% | $54.3M |
| TLPH | Talphera Inc. | $1.07 | -0.93% | $55.5M |
| CLNN | Clene Inc. | $3.39 | -7.88% | $48.2M |
| HOWL | Werewolf Therapeutics Inc. | $0.9911 | +0.95% | $48.2M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier